Targeting vaccinations for the licensed dengue vaccine: Considerations for serosurvey design.
<h4>Background</h4>The CYD-TDV vaccine was unusual in that the recommended target population for vaccination was originally defined not only by age, but also by transmission setting as defined by seroprevalence. WHO originally recommended countries consider vaccination against dengue wit...
Main Authors: | Natsuko Imai, Neil M Ferguson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0199450 |
Similar Items
-
Vaccines licensed and in clinical trials for the prevention of dengue
by: J. Torresi, et al.
Published: (2017-05-01) -
Dengue serosurvey in Sint Eustatius.
by: Teresa Leslie, et al.
Published: (2014-01-01) -
Exploring the role of a recently licensed dengue vaccine in Australian travellers
by: Thevarajan, I, et al.
Published: (2020) -
Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers
by: Andrea Trevisan, et al.
Published: (2021-04-01) -
Rubella serosurvey and factors related to vaccine hesitancy in childbearing women in Italy
by: Matteo Boattini, et al.
Published: (2019-09-01)